Instillagel

Chlorhexidine Gluconate, the active ingredient in Instillagel, is an antiseptic; Lidocaine Hydrochloride, the active ingredient in Instillagel, is a local anesthetic presented as a gel for urethral use. It delivers broad‑spectrum antimicrobial protection and temporary numbness to the urethral mucosa during catheterisation and related urological interventions.

GNH USA supplies Instillagel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics throughout worldwide, ensuring consistent quality, regulatory compliance and reliable logistics for sterile urological products.

Instillagel, a combined antiseptic and local anaesthetic, is used in urological procedures to manage infection risk and discomfort. - Urethral antisepsis: Reduces bacterial colonisation of the urethra during catheter insertion or manipulation. - Prevention of urinary tract infection during catheterisation: Lowers incidence of catheter‑associated urinary tract infections in patients requiring short‑term or long‑term catheter use. - Urethral analgesia: Provides temporary numbness to ease discomfort during catheterisation, cystoscopy or other urethral interventions.

Instillagel may cause local or systemic reactions, although most users experience minimal irritation.

Common Side Effects: - Burning sensation: Transient mild burning or stinging at the application site. - Redness: Local erythema of the urethral mucosa. - Discomfort: Brief discomfort or urge to void following instillation. - Mild headache: Occasional headache not directly related to the urethra.

Serious or Rare Side Effects: - Allergic reaction: Urticaria, angioedema, or anaphylaxis requiring immediate medical attention. - Severe urethral irritation: Persistent pain, swelling, or ulceration of the urethral tissue. - Systemic toxicity: Signs of lidocaine toxicity such as dizziness, tinnitus, or cardiac arrhythmia. - Infection: Secondary infection if sterility is compromised.

When using Instillagel, consider the following precautions to ensure safety and efficacy. - Patient assessment: Verify absence of known hypersensitivity to chlorhexidine, lidocaine or related compounds before administration. - Contraindications: Avoid use in patients with a history of severe allergic reactions to antiseptics or local anaesthetics. - Pregnancy and lactation: Use only if the potential benefit outweighs the potential risk; data are limited. - Interaction with other urethral products: Do not combine with other antiseptic solutions or medicated gels without professional guidance. - Monitoring: Observe the patient for signs of local irritation or systemic reactions during and after instillation. - Store at ambient temperature: Keep the gel below 25 °C in the original container, protected from moisture and direct sunlight.

Instillagel can interact with certain medications or substances; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Systemic lidocaine: Concurrent high‑dose systemic lidocaine may increase risk of toxicity. - Other chlorhexidine products: Simultaneous use can lead to excessive antiseptic exposure and mucosal irritation.

Moderate Interactions (Monitor Closely): - Anticoagulants: Chlorhexidine may potentiate bleeding risk if mucosal integrity is compromised. - Beta‑blockers: Lidocaine can enhance the effects of beta‑blockers on cardiac conduction. - Local irritants: Use with other irritating urethral agents may exacerbate discomfort.